MAC
CORZ icon

Monarch Alternative Capital’s Core Scientific CORZ Stock Holding History

Monarch Alternative Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Buy
+4,600,000
New +$108M 16.65% 4

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Monarch Alternative Capital's CORZ Position: Q2 2026 in Review

Monarch Alternative Capital opened a new position in Core Scientific (CORZ) in Q2 2026: 4,600,000 shares worth $118M. The stake represents 16.65% of the portfolio and ranks #4 among its holdings.

412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Monarch Alternative Capital held 4,600,000 shares of Core Scientific worth $118M as of Q2 2026.
  • Core Scientific was a new Monarch Alternative Capital position in Q2 2026.
  • Core Scientific made up 16.65% of Monarch Alternative Capital's portfolio in Q2 2026, its #4 holding.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Monarch Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.